Articles tagged with: BMY
Dapagliflozin meets endpoints (NYSE:BMY)
It was announced today that Bristol-Myers Squibb (NYSE:BMY) and AstraZeneca’s diabetes drug dapagliflozin has successfully met the endpoints in the first phase III study. The companies together stated that their diabetes drug was able to …
Rumor of Acquisition is getting real (SPPI, BMY, PFE, WYE, MRK, SGP, ALTI)
If you are a follower of the abundant rumors, predictions, and speculation that flows around the biotech industry you may have heard that Spectrum Pharmaceuticals (SPPI) may be targeted for acquisition by either Bayer Schering …
